Form 8-K - Current report:
SEC Accession No. 0001193125-25-154057
Filing Date
2025-07-01
Accepted
2025-07-01 16:40:23
Documents
18
Period of Report
2025-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d38498d8k.htm   iXBRL 8-K 35043
2 EX-1.1 d38498dex11.htm EX-1.1 224742
3 EX-5.1 d38498dex51.htm EX-5.1 10222
4 EX-99.1 d38498dex991.htm EX-99.1 9240
8 GRAPHIC g38498g0701080803618.jpg GRAPHIC 1649
9 GRAPHIC g38498g0701081121665.jpg GRAPHIC 3002
10 GRAPHIC g38498g0701083416685.jpg GRAPHIC 5595
  Complete submission text file 0001193125-25-154057.txt   475926

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dyn-20250630.xsd EX-101.SCH 2847
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20250630_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20250630_pre.xml EX-101.PRE 10811
20 EXTRACTED XBRL INSTANCE DOCUMENT d38498d8k_htm.xml XML 3497
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 251096983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)